Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Improving Medication Adherence in Breast Cancer Using a CONnected CUstomized Treatment Platform (CONCURxP)

NCT06112613 is registered in ClinicalTrials.gov with ECOG-ACRIN Cancer Research Group as lead sponsor.

NCT NCT06112613
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06112613 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Improving Medication Adherence in Breast Cancer Using a CONnected CUstomized Treatment Platform (CONCURxP)
Lead sponsor
ECOG-ACRIN Cancer Research Group
Phase
Not applicable
Overall status
Active, not recruiting
Start date
April 2, 2024
Completion date
September 22, 2027
Enrollment
390 (estimated)
Sites
506

Conditions

As the registry lists them; a condition with its own page is linked.

breast carcinoma